Validation of a Rapid Immunochromatographic Assay for Diagnosis of Trypanosoma cruzi Infection among Latin-American Migrants in Geneva, Switzerland
- 1 August 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (8), 2948-2952
- https://doi.org/10.1128/jcm.00774-10
Abstract
Chagas' disease is a global public health problem due to the recent exchange of population between Latin America and other regions, including Europe. The recent development of rapid diagnostic tests (RDTs) for Trypanosoma cruzi infection may improve patient access to diagnosis and care worldwide. We evaluated the diagnostic accuracy of the Chagas Stat-Pak RDT in a cohort of undocumented Latin-American migrants living in Geneva, Switzerland. Study participants were enrolled in a primary health care center. The Chagas Stat-Pak test was performed independently on blood and serum samples. A combination of two commercialized enzyme-linked immunosorbent assay (ELISA)-based serological tests was used for comparison (reference standard). A total of 999 adults (median age, 36 years) were included in the study; the majority were women (83%) and originally from Bolivia (47%) or Brazil (25%). A total of 125 participants (12.5%) were diagnosed with T. cruzi infection; with the exception of three individuals, all individuals diagnosed with T. cruzi were originally from Bolivia. The sensitivity and specificity of the Chagas Stat-Pak test on blood samples were 95.2% (95% confidence interval [95% CI], 89.2% to 97.9%) and 99.9% (95% CI, 99.3% to 100%), respectively. When the test was performed on serum samples, the sensitivity was 96% (95% CI, 91% to 98.3%), and the specificity was 99.8% (95% CI, 99.2% to 99.9%). The concordance of test results for blood and serum samples was 99.7%. Both negative and positive predictive values were above 98%. The Chagas Stat-Pak is an accurate diagnostic test for T. cruzi infection among Latin-American migrants living in Europe. The mild deficit in sensitivity should be interpreted in light of its ease of use and capacity to provide immediate results, which allow more people at risk to have access to diagnosis and care both in countries where Chagas' disease is endemic and in countries where this disease is not endemic.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence, Clinical Staging and Risk for Blood-Borne Transmission of Chagas Disease among Latin American Migrants in Geneva, SwitzerlandPLoS Neglected Tropical Diseases, 2010
- Sensitivity and specificity of Chagas Stat‐Pak® test in BoliviaTropical Medicine & International Health, 2009
- WHO comparative evaluation of serologic assays for Chagas diseaseTransfusion, 2009
- Chagasic Cardiomyopathy in Immigrants from Latin America to SpainEmerging Infectious Diseases, 2009
- Congenital Transmission of Chagas Disease in Latin American Immigrants in SwitzerlandEmerging Infectious Diseases, 2009
- Evaluation of SD BIOLINE Chagas Ab Rapid KitAnnals of Laboratory Medicine, 2009
- Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole BloodJournal of Clinical Microbiology, 2008
- International meeting: new diagnostic tests are urgently needed to treat patients with Chagas diseaseRevista da Sociedade Brasileira de Medicina Tropical, 2008
- Chagas cardiomyopathy: Europe is not spared!European Heart Journal, 2008
- Validation of a Rapid and Reliable Test for Diagnosis of Chagas' Disease by Detection of Trypanosoma cruzi -Specific Antibodies in Blood of Donors and Patients in Central AmericaJournal of Clinical Microbiology, 2005